BioSpace News Archive

Transparency Market Research has published a new report titled, ‘Mobile Imaging Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

According to the report, the global pelvic floor electrical stimulation devices market was valued at US$ 300 Mn in 2019 and is projected to expand at a CAGR of 9.5% from 2020 to 2030.

A Nomination Committee consisting of members appointed by the three largest shareholders or group of shareholders and the Chairman of the Board of Directors has been formed for Biotage AB in accordance with the principles adopted by the annual general meeting held on 4 June 2020.

Gunze Limited [TOKYO:3002] is pleased to announce that Gunze’s biodegradable scaffolds are being provided to the Abigail Wexner Research Institute at Nationwide Children’s Hospital to conduct its first human tissue engineered vascular grafts, clinical trial.

OraSure Technologies, Inc., a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced that its ORAcollect®·RNA saliva collection device has been included in the U.S. Food and Drug Administration Emergency Use Authorization granted to Quadrant Biosciences Inc. for a COVID-19 laboratory test.

Oral presentation of interim results from TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) open-label safety extension study to be presented at the ECFS Digital Conference

In2Bones Global, Inc. announces the U.S. launch of its CoLink® Cfx Calcaneal Fixation System.

IDEAYA Biosciences, Inc. announced that it has expanded its clinical trial collaboration and supply agreement with Pfizer Inc. for an IDEAYA sponsored clinical combination study of IDE196, a Protein Kinase C inhibitor, and crizotinib, a cMET inhibitor to which Pfizer has exclusive worldwide rights.

Generation Bio Co., an innovative genetic medicines company creating a new class of non-viral gene therapy, announced that Geoff McDonough, M.D., president and chief executive officer, will present at the Jefferies 2020 Virtual Gene Therapy/Editing Summit on Thursday, Oct. 1 at 11:00 a.m. ET.

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange, announced positive clinical findings published in Cancer Chemotherapy and Pharmacology regarding MN-166 as a treatment for prevention of chemotherapy-induced peripheral neuropathy.